« POPE IV Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next

Re: Sarepta 

By: Decomposed in POPE IV | Recommend this post (2)
Mon, 19 Sep 16 8:49 PM | 71 view(s)
Boardmark this board | POPES NEW and Improved Real Board
Msg. 11285 of 47202
(This msg. is a reply to 06137 by Decomposed)

Jump:
Jump to board:
Jump to msg. #

It's been a while, but Sarepta's drug (which I've been blogging about since October) gained FDA approval this morning and the stock is currently up 80 percent, to $51.26. As you can see below, it was $16 on May 2nd. It actually fell to $8 after a particularly scathing FDA review earlier this year.

Given that the market for the drug is smaller than I thought (only 14% of the MD patients qualify for it), I am exiting my position. 





Avatar

Gold is $1,581/oz today. When it hits $2,000, it will be up 26.5%. Let's see how long that takes. - De 3/11/2013 - ANSWER: 7 Years, 5 Months


- - - - -
View Replies (1) »



» You can also:
- - - - -
The above is a reply to the following message:
Sarepta
By: Decomposed
in POPE IV
Mon, 02 May 16 11:37 PM
Msg. 06137 of 47202

SRPT is up another 15 percent today - and trading considerably higher than it was before the 'Bad news.' The story I've heard is that the FDA is under a lot of pressure to do something positive for Muscular Dystrophy patients and might approve the drug despite the negative vote by the FDA panel.

The cost / benefit ratio is favorable. In other words, if they reject eteplirsen, the stock could fall by $16. If they approve eteplirsen, the stock shoots to $100. That makes it worth buying for those who think the odds of approval are better than one in six.
 


Uploaded Image


« POPE IV Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next